Fig. 6.

Medication details of patients in group 2 and 3 (n = 46). Group 2 (definite ACS) acute coronary syndrome and Group 3 (CK-MB anomalies) a those with definite cardiac involvement, termed as CARD (n = 26, 17 M, 9 F), drug chart available in 19/26 patients. Group 3 (CK-MB anomalies) b patients with no cardiac involvement, termed as NONCARD (n = 20, 8 M, 2 F) drug chart available in 17/20 patients. C median number of drugs 4 (range 0–16). NC median number of drugs 5 (range 0–16). Histogram shows Frusemide, PP Inhibitors (Proton pump inhibitors), Morphine, statins, Aspirin, Paracetamol, Clopidogrel (Anti-platelet) (ISD) Isosorbide Dinitrate, Antibiotic, various Antibiotics, hydrocortisone